Advanced Wound Dressing Products Industry| Revolutionizing Wound Care | Data Book to 203011/28/2023 Global advanced wound dressing products industry databook, published by Grand View Research’s is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Access the Global Advanced Wound Dressing Products Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Foam Dressings Market Insights The global foam dressings market generated over USD 1.7 Billion revenue in 2022 and is projected to expand at a CAGR of around 4.71% during the forecast period. A few of the key drivers propelling the market growth include an increase in surgical cases, a rapidly aging population, and an increase in the number of diabetes patients. For instance, according to the World Economic Forum, the current population of Japanese people above 65 years of age is 25% of the total population. This number is further expected to rise to 40% by 2060. Older people are more likely to sustain wounds, thus, the market for foam dressing is expected to grow throughout the forecast period. An increase in the number of obese/overweight people is another fueling factor of the market. For instance, according to an article by Sage Journals & Indian Academy of Neurosciences, 2021, the number of obese people in India is estimated to be 135 million. Similarly, as per the Obesity Evidence Hub, two-thirds of the Australian people, i.e., 35.6% are overweight, whereas, 31.3% are expected to be obese. These situations are anticipated to raise demand for bariatric treatments and other related surgeries, driving the growth of the market over the anticipated time frame. Hydrocolloid Dressings Market Insights The global hydrocolloid dressings market generated over USD 1.3 Billion revenue in 2022 and is projected to expand at a CAGR of around 5.01% during the forecast period. Increasing prevalence of chronic and acute wounds, rapidly aging population, rising number of diabetic patients, and surge in research and development activities are among the major factors driving the market growth. The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, among the general population is likely to increase the number of patients getting treatment and fuel the adoption of hydrocolloid dressings. Furthermore, the rising prevalence of acute wounds, such as surgical wounds and burns, is further expected to drive the demand for hydrocolloid wound dressings throughout the projected period. Surgical wounds, for example, are a major problem in general healthcare, according to the Wound Healing Society (WHS). Despite all attempts, Surgical Site Infections (SSI) cause death in 75% of patients globally. As a result, the increased incidence of infections has imposed a significant cost burden on the healthcare business. This is likely to contribute to the launch of advanced products, thus fostering market growth. Clinical uses for several hydrocolloid materials have been proposed in recent years. Film Dressings Market Insights The global film dressings market generated over USD 1.5 Billion revenue in 2022 and is projected to expand at a CAGR of around 4.57% during the forecast period. The film dressing market growth can be accredited to the rising prevalence of chronic wounds, globally. People with diabetic foot ulcers are becoming more common, due to the rise in the population of those with chronic illnesses such as diabetes. For instance, the International Diabetes Federation estimates that 61 million people in Europe between the age of 20 and 79 have diabetes. The incidence rate of diabetic foot ulcers, according to NCBI, ranges from 9.1 million to 26.1 million per year worldwide. Thus, the rise in diabetes and diabetic foot ulcer patients is driving the film dressing market during the forecast period. Additionally, the number of traumatic events such as burns, gunshot wounds, and car accidents has increased, globally. For instance, as per the WHO estimates there are 11.0 million burn cases, worldwide, resulting in 180,000 fatalities every year. Similar to this, more than 30,000 burn cases are reported daily, worldwide, according to NCBI. Therefore, it is projected that the film dressings market would be driven by the rising number of burn cases, worldwide, during the forecast period. Order your copy of the Free Sample of Advanced Wound Dressing Products Industry Data Book, published by Grand View Research Alginate Dressings Market insights The global alginate dressings market generated over USD 902.9 Million revenue in 2022 and is projected to expand at a CAGR of around 4.13% during the forecast period. The market growth is mainly driven by the rising prevalence of chronic & acute wounds globally. For instance, as per a study by the NCBI, the prevalence rate of chronic wounds in the general population was calculated to be 2.21 per 1,000 populations in 2018. Similarly, as per Lippincot Williams & Wilkins Journals, the total prevalence rate of chronic wounds was estimated to be 16.8 per 1,000 hospital inpatients in Northern China. Thereby, impelling the industry growth. In addition, an increase in the number of traumatic accidents, such as road accidents, burn cases, gunshot wounds, etc., across the globe is expected to further boost industry growth. For instance, according to the National Highway Traffic Safety Administration, an estimated 38,680 people died in 2020 as a result of motor vehicle crashes. This was a 7.2% increase from 2019. Moreover, as per American Burn Association, every year around 450,000 burn cases, which require medical attention, are reported in the U.S. alone.Furthermore, the industry is expected to propel post-pandemic due to an increase in the volumes of surgeries post-COVID-19. In addition, industry players are entering into various strategic alliances, such as partnerships, mergers, acquisitions, product launches, and geographic expansion. For instance, Medline Industries invested USD 1.5 billion in strengthening its domestic supply chain to meet the growing demand. These initiatives are expected to help the market grow over the forecast period. Hydrogel Dressings Market Insights The global hydrogel dressings market generated over USD 883.8 Million revenue in 2022 and is projected to expand at a CAGR of around 4.30% during the forecast period. The market growth can be accredited to the rising prevalence of chronic wounds globally. The properties of hydrogel-based dressings can be adjusted much more easily compared to conventional chronic wound therapy methods. Moreover, owing to their adaptability and versatility, hydrogel dressings can be loaded with cells, antibacterial, antiviral, and antifungal agents, growth factors, and biomolecules to hasten wound contraction and healing. Furthermore, their ability to create in situ and cytocompatible chemical crosslinking these dressings may be easily applied to irregular or deep wounds. Thereby, owing to the above-mentioned advantages is expected to impel the hydrogel dressing market. Massive research is being conducted in order to create novel hydrogel products from natural sources such as animal tissues, plant extracts, extracellular matrix, and others. Firms are extensively spending on R&D and are continuously working on achieving positive clinical trial results. For instance, Remedor Biomed Ltd. is conducting clinical studies on a hydrogel containing erythropoietin to treat diabetic foot ulcers. In addition, a variety of peptides are being studied in clinical studies for their wound-healing abilities. Thus, rigorous clinical studies to commercialize novel hydrogel dressing products are expected to drive the growth of the hydrogel dressing market in the near term. Collagen Dressings Market Insights The global collagen dressings market generated over USD 691.7 Million revenue in 2022 and is projected to expand at a CAGR of around 3.77% during the forecast period. This can be attributed primarily to the increase in the number of people suffering from various chronic disorders such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. For instance, according to the Agency for Healthcare Research and Quality, every year, more than 2.5 million U.S. residents suffer from pressure ulcers. These are associated with serious infections; therefore, the use of collagen dressing is expected to increase over the forecast duration. Moreover, a rise in the number of people suffering from leg ulcers may further propel the market growth. For instance, as per NCBI, around 1.5 – 3.0 people in 3,000 have an active leg ulcer at any given point. Similarly, according to the National Health Service, venous leg ulcers are estimated to affect about one in 500 residents in the U.K., thereby boosting the market over the forecast period. Go through the table of content of Advanced Wound Dressing Products Industry Data Book to get a better understanding of the Coverage & Scope of the study. Advanced Wound Dressing Products Industry Data Book Competitive Landscape The market is highly fragmented in nature with the presence of several small and large manufacturers. Competitive rivalry and degree of competition in the wound market is expected to intensify over the forecast period due to the presence of many players in the market. Furthermore, leading players are involved in collaborations, product launches, mergers and acquisitions to strengthen their product portfolios. Key players operating in the advanced wound dressing products industry are – • Smith & Nephew • Molnlycke Health Care AB • ConvaTec Group PLC • Baxter International • URGO Medical • Coloplast Corp. • Medtronic • 3M • Derma Sciences Inc. (Integra LifeSciences) • Medline Industries
0 Comments
Global Ultrasound devices and accessories industry databook is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Ultrasound Device Market Insights The global ultrasound device market size was estimated at USD 10.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030. The market is expected to experience steady growth during the forecast period. This is attributed to several factors such as increased adoption of ultrasonography for diagnostic and therapeutic applications, rising technological advancements, as well an increase in the number of product launches by key players operating in the market. Emerging innovations in ultrasound technology are expanding the market size. Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities globally. Furthermore, the introduction of 3D/4D ultrasound and the integration of artificial intelligence (Al) to automate time-consuming processes are expected to propel market growth during the forecast period. For instance, in July 2023, Sonosite ST was introduced by FUJIFILM Sonosite ST. It has a 21-inch touchscreen with an all-touch interface, a 10" by 7.5" image area, automated setting optimization for each exam type, and Auto Steep Needle Profiling (SNP). To support system compatibility, Sonosite ST belongs to the same family of transducers as Sonosite PX and Sonosite LX. The growing use of ultrasound equipment for diagnostic imaging and therapy, as well as the rising prevalence of chronic and lifestyle-related illnesses are the key factors anticipating the market’s growth. Ultrasound technology is used in various application areas such as cardiology, obstetrics/ gynecology, vascular, orthopedic, and general imaging. The rising prevalence of cardiac disorders is expected to boost the market globally. According to WHO, Cardiovascular diseases (CVDs) are the major cause of death globally, taking approximately 17.9 million lives each year. In addition, as per the Centers for Disease Control & Prevention, in the United States, every year about 805,000 people have a heart attack, and about 1 in 20 adults aged 20 and older has coronary artery disease (about 5%). Access the Global Ultrasound Devices and Accessories Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Ultrasound Transducer Market Insights The global ultrasound transducer market size was valued at USD 3.3 billion in 2022 and is expected to expand at a CAGR of 4.8% from 2023 to 2030. It is expected to expand at a CAGR of 3.6% during the forecast period. Increasing number of product launches and growing focus of the major players on innovations for safe and accurate diagnosis are the factors driving the growth. North America is anticipated to hold substantial share of the market during the forecast period owing to high adoption of advanced medical devices. Continuous innovations in ultrasound machine such as portable and mobile ultrasound machine is expected to fuel the growth. Moreover, presence of a large number of ultrasound transducer manufacturers is anticipated to bode well for the regional growth. These companies emphasize on heavy investments to develop smart production methods and process automation, which is a key factor in optimizing product prices and maximizing revenues. Another innovation pertaining to these devices include burst wave lithotripsy which help delicate procedures including kidney stone destruction. The technology is not only efficient but also offers non-invasive procedure to patients, which is anticipated to ultimately augment the product demand in the forthcoming years. Growing number of partnerships between resellers for ultrasound transducers is an emerging trend witnessed in the market. Direct purchase from Original Equipment Manufacturers (OEMs) is another trend observed in the market. End users are increasingly dealing with OEMs since they offer efficient technologies like custom strain gauge sensing to finished product designs, to achieve greater business advantage. Ultrasound Gels Market insights The global ultrasound gel market size was valued at USD 101.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 2.6% from 2023 to 2030. The increasing adoption rate of ultrasound devices in healthcare settings due to its diagnostic efficiency and cost-effectiveness is the factor expected to drive the demand for the conductive medium during the forecast period. In addition, the increasing number of external sonography procedures requiring a low level of sterility has contributed to its largest market share. Increasing patient visits reporting problems such as heart disease, kidney and gallbladder problems, and lung and intestinal diseases where ultrasound primarily finds application is expected to increase the consumption rate of the gel. Growing concern to protect the ultrasound transducer from damages and the developing trend to provide utmost patient satisfaction during treatment has led to increasing demand for odorless, colorless, and stain-free ultrasound gels. The availability of handheld sonography devices at affordable prices has promoted their adoption rate in small-sized clinics. Therefore, the growing installation rate of sonography units in clinics has contributed to the rising demand of gel in these setups. Availability of alternative to ultrasound gels, the advent of gel-free sonography probes, and limited access to medical consumables in rural areas are expected to resist the growth of the market during the forecast period. The gel-free sonography probes can be a major threat to the market, but its expensiveness is limiting its adoption rate. Order your copy of the Free Sample of “Ultrasound Devices and Accessories Industry Data Book - Ultrasound Device, Ultrasound Transducer and Ultrasound Gels Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Ultrasound Devices and Accessories Industry Data Book Competitive Landscape The major players are working to improve their product offerings by upgrading their products, taking advantage of important cooperation activities, and exploring acquisitions and government clearances in order to expand their customer base and gain a larger share of the overall market. Key players operating in the ultrasound devices and accessories industry are – • Compass Health Brands • ECO-MED • National Therapy Products • H.R Pharmaceuticals Inc • Tele-Paper Malaysia • Sonogel Vertriebs • Medline Industries, Inc • Parker Laboratories • Ultragel Kft. Patient Monitoring Devices Industry Emerging Trends, Technologies And Revolutionizing Healthcare11/22/2023 Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Covers Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market. Grand View Research’s magnetic resonance imaging scanners and accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. Access the Global Magnetic Resonance Imaging Scanners and Accessories Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Magnetic Resonance Imaging Market Insights The global magnetic resonance imaging market size is expected to reach USD 10.29 billion by 2030, registering a CAGR of 6.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of chronic diseases and increasing demand for early diagnostic techniques are the factors expected to drive the market growth. In addition, the growing adoption of less invasive procedures is contributing to the market growth. Moreover, the growing number of clinical trials to understand the effectiveness and efficiency of MRI machines in various clinical applications is expected to boost market growth. End-users, such as research institutes and universities, are actively conducting studies to assess the effectiveness of high-field strength MRI devices, including those with field strengths of 7T, 10T, and 10.5T. The increasing number of research investigations will contribute to unveiling the potential uses and benefits of high-field MRI machines for a wide range of both preclinical and clinical applications. Technological advancements are further expected to boost the industry growth. The introduction of new software has resulted in quicker scanning and streamlined imaging workflows. Recent progress has facilitated the creation of multi-contrast and cardiac MRI, enhancing imaging capabilities. Software updates provide users with the opportunity to enhance their systems and improve workflow efficiency. As an illustration, in November 2021, Philips unveiled an AI-enabled MR imaging portfolio designed to enhance radiology operations' efficiency and sustainability. This portfolio accelerates MR exams, simplifies workflows, enhances diagnostic quality, and ensures the overall efficiency and sustainability of radiology operations. MRI Coils Market Insights The global magnetic resonance imaging coils market size is expected to reach USD 15.79 billion by 2030, expanding at 8.7% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. According to the WHO, neurological disorders are responsible for more than 10% of the worldwide burden of disease, with stroke and dementia being the most common causes of disability and death. This is driving the scope of magnetic resonance imaging (MRI) coils globally. In addition, technological advancements are also playing a key role in growth worldwide. COVID-19 had a significant impact on the industry. The major impact of the pandemic on the imaging diagnostics sector was the disruption of the global supply chain. The manufacturing of MRI coils is a complex process that involves the use of specialized materials and equipment. The pandemic caused disruptions in the availability of these materials and appliances, leading to delays in the production and distribution of magnetic resonance imaging (MRI) coils. However, the introduction of multipurpose diagnostics is one of the major factors fuelling the market growth. Increasing use of advanced equipment for rapid diagnosis and predictive analysis in various countries is anticipated to contribute to the market. Various factors, such as increasing demand for early diagnosis of chronic diseases and the growing geriatric population, are likely to boost the demand for the sector. Order your copy of the Free Sample of “Magnetic Resonance Imaging Scanners and Accessories Industry Data Book - Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Motion Tracking Systems Market Insights The global MRI motion tracking systems market size is expected to reach USD 12.48 million by 2030 registering a CAGR of 20.7% according to a new report by Grand View Research, Inc. The increased need by radiologists to capture sharp and clear images with reduced artifacts minimized errors, and reduced need for multiple MRI scans, are factors influencing the growth of the industry. During MRI scans, especially brain scans, the patient’s head must remain still, which often causes discomfort to the patients, resulting in unclear and blurred images. This ultimately prevents the radiologists from effectively analyzing MRI images and forces them to conduct multiple scans. Unnecessary scans cause a great economic burden on the hospital, radiologist, and insurer. Hence, it calls for systems such as motion tracking that saves analysis time, ensure patient comfort, and improve diagnostic capabilities. Numerous research is been conducted in this space to determine system efficacy, safety, and accuracy. Motion tracking systems from new market entrants like Metria Innovations are being used by numerous research institutes and universities and are soon to receive FDA approval for product launch. Various universities are developing their systems for research purposes and may file FDA approvals for the same. Hence, the market holds great potential for new entrants as there is a limited presence of highly sophisticated systems at the moment. Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Competitive Landscape The high price is one of the most impeding factors for the sales of these systems. The major players are focusing on minimizing the prices for medium-strength MRI systems using various methods. Technological advancements in manufacturing and the high influx of these systems in the market is expected to bring the prices down in the upcoming years. Key players operating in the Magnetic Resonance Imaging Scanners and Accessories Industry are – • GE Healthcare • Siemens Healthineers • Toshiba Corporation • Aurora Imaging Technologies, Inc. • Koninklijke Philips N.V. • Esaote SPA • Sanrad Medical Systems Pvt ltd • Fujifilm • MR Instruments, Inc. • RAPID MR International, LLC • ScanMed • Canon Medical Systems Corporation • Hologic Inc. • Bruker • TracInnovations • Kineticor • Metria Innovations Stem cells industry data book covers human embryonic stem cells, induced pluripotent stem cells production, mesenchymal stem cells, stem cells and cancer stem cells market. Grand View Research’s Stem Cells Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview. Access the Global Stem Cells Industry Industry Data Book from 2023 to 2030, compiled with details by Grand View Research Human Embryonic Stem Cells Market Insights The global human embryonic stem cells market size was valued USD 1.10 billion in 2022 with a CAGR of 10.6% during 2023-2030, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft. Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake. In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency. Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment. However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques. Induced Pluripotent Stem Cells Market Insights The induced pluripotent stem cells production market was valued at USD 1.36 Billion in 2022 and the market is expected to expand at a CAGR of 9.3% from 2023 to 2030. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021. The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19. Order your copy of the Free Sample of “Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research Mesenchymal Stem Cells Market insights The global mesenchymal stem cells market size is expected to reach USD 3.02 Billion in 2022, the market is expected to reach at a CAGR of 11.4% from 2023 to 2030. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence. The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U.S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth. Cancer Stem Cells Market Insights The global cancer stem cells market size was reached USD 2.59 billion in 2022, according to a new report by Grand View Research, Inc., expanding at a CAGR of 12.1% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells. Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market. Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome. Stem Cells Market Insights The global stem cells market size was valued USD 13.26 billion in 2022, registering a CAGR of 11.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors. The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies. Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery. Go through the table of content of Stem Cells Industry Data Book to get a better understanding of the Coverage & Scope of the study. Stem Cells Industry Data Book Competitive Landscape Competitive rivalry in the stem cell industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space. Key players operating in the stem cells industry are – • STEMCELL Technologies Inc. • Advanced Cell Technology Inc. • Cellular Engineering Technologies Inc. • CellGenix GmbH • Angel Biotechnology • PromoCell GmbH • Kite Pharma • Lonza • Cellartis AB • Celgene Corporation • Brainstorm Cell Therapeutics • Osiris Therapeutics • Genea Biocells • Waisman Biomanufacturing • Bioheart Inc. • Tigenix • Caladrius Biosciences • Gamida Cell |
Archives
December 2023
Categories |